Solstein Capital LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Solstein Capital LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 104.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 151 shares of the medical equipment provider’s stock after acquiring an additional 77 shares during the period. Solstein Capital LLC’s holdings in Intuitive Surgical were worth $82,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. lifted its stake in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after purchasing an additional 71,794 shares in the last quarter. Northern Trust Corp lifted its stake in Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP lifted its stake in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Intuitive Surgical during the first quarter worth $1,715,899,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,031 shares of company stock worth $14,177,895. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $546.51 on Monday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $195.91 billion, a PE ratio of 72.29, a P/E/G ratio of 5.02 and a beta of 1.61. The stock’s fifty day moving average is $458.09 and its two-hundred day moving average is $497.11.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the firm earned $1.84 earnings per share. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ISRG. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. Mizuho set a $575.00 price target on Intuitive Surgical in a research note on Wednesday. Evercore ISI reduced their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 7th. UBS Group set a $600.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a report on Thursday. Finally, The Goldman Sachs Group decreased their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.